Marra Alexandre R, de Matos Gustavo Faissol Janot, Janeri Renata Donato, Machado Patricia Sousa, Schvartsman Claudio, Dos Santos Oscar Fernando Pavão
Intensive Care Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.
BMC Res Notes. 2011 Sep 8;4:335. doi: 10.1186/1756-0500-4-335.
Dengue fever is one of the most common tropical diseases worldwide. Early detection of the disease, followed by intravenous fluid therapy in patients with dengue hemorrhagic fever (DHF) or with warning signs of dengue has a major impact on the prognosis. The purpose of this study is to describe the care provided in a hydration tent, including early detection, treatment, and serial follow-up of patients with dengue fever.
The analysis included all patients treated in the hydration tent from April 8 to May 9, 2008. The tent was set up inside the premises of the 2nd Military Firemen Group, located in Meier, a neighborhood in Rio de Janeiro, Brazil. The case form data were stored in a computerized database for subsequent assessment. Patients were referred to the tent from primary care units and from secondary city and state hospitals. The routine procedure consisted of an initial screening including vital signs (temperature, blood pressure, heart rate, and respiratory rate), tourniquet test and blood sampling for complete blood count. Over a 31-day period, 3,393 case recordings were seen at the hydration tent. The mean was 109 patients per day. A total of 2,102 initial visits and 1,291 return visits were conducted. Of the patients who returned to the hydration tent for reevaluation, 850 returned once, 230 returned twice, 114 returned three times, and 97 returned four times or more. Overall, 93 (5.3%) patients with DHF seen at the tent were transferred to a tertiary hospital. There were no deaths among these patients.
As the epidemics were already widespread and there were no technical conditions for routine serology, all cases of suspected dengue fever were treated as such. Implementing hydration tents decrease the number of dengue fever hospitalizations.
登革热是全球最常见的热带疾病之一。早期发现该疾病,并对登革出血热(DHF)患者或有登革热预警信号的患者进行静脉补液治疗,对预后有重大影响。本研究的目的是描述在补液帐篷中提供的护理,包括登革热患者的早期发现、治疗和连续随访。
分析纳入了2008年4月8日至5月9日在补液帐篷接受治疗的所有患者。该帐篷设置在位于巴西里约热内卢一个街区迈耶的第二军事消防员大队驻地内。病例表格数据存储在计算机化数据库中以供后续评估。患者从初级保健单位以及城市和州二级医院转诊至该帐篷。常规程序包括初步筛查,内容有生命体征(体温、血压、心率和呼吸频率)、束臂试验以及采集全血细胞计数的血样。在31天的时间里,补液帐篷共记录了3393例病例。平均每天109例患者。共进行了2102次初诊和1291次复诊。在返回补液帐篷进行重新评估的患者中,850人返回一次,230人返回两次,114人返回三次,97人返回四次或更多次。总体而言,在该帐篷就诊的93例(5.3%)DHF患者被转诊至三级医院。这些患者中无死亡病例。
由于疫情已经广泛传播且没有进行常规血清学检测的技术条件,所有疑似登革热病例均按此进行治疗。设置补液帐篷减少了登革热住院病例数。